Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors
Open Access
- 31 December 2004
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (12), 877-882
- https://doi.org/10.1016/j.bbmt.2004.08.002
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantationTissue Antigens, 2003
- G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II–IVBone Marrow Transplantation, 2003
- Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donorsBone Marrow Transplantation, 2002
- Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemiaBone Marrow Transplantation, 1999
- Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapyTransplantation and Cellular Therapy, 1999
- Basic Fibroblast Growth Factor Protects against Excitotoxicity and Chemical Hypoxia in Both Neonatal and Adult RatsJournal of Cerebral Blood Flow & Metabolism, 1995
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- TRANSPLANTATION IN RELATION TO THE TREATMENT OF INHERITED DISEASETransplantation, 1984
- BONE MARROW TRANSPLANTATION FOR INBORN ERRORSThe Lancet, 1981
- Marrow Transplantation for Treatment of Aplastic AnemiaNew England Journal of Medicine, 1977